Emerging Markets Health Care -- A Unique Challenge

By Brenton Flynn, Dave Williamson, and Max Macaluso – Dec 19, 2012 at 6:30PM

NYSE: JNJ

Johnson & Johnson

Market Cap

$354B

Today's Change

(-1.15%) -$1.71

Current Price

$146.82

Price as of April 25, 2024, 4:00 p.m. ET

In this part of our roundtable discussion, how JNJ could see some growth in its medical devices sector, if it could tap the difficult emerging markets.

Our health care roundtable gathers the Motley Fool's top health care analysts to discuss the sector's biggest stories in a free flowing and highly opinionated format.

In this portion of the video, the guys discuss one of Johnson & Johnson's (JNJ -1.15%) major acquisitions in the medical devices space and whether it was a good idea considering that the company has seen some slowdown in that area. They discuss the huge potential with rapidly growing emerging markets and the difficulty in tapping those markets when the people there simply don't have as much money to spend.

Brenton Flynn and David Williamson have no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson and Medtronic and has the following options: short MAY 2013 $44.00 calls on Medtronic. Motley Fool newsletter services recommend Johnson & Johnson. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.